NEUROSTECH designs and develops innovative medical devices advancing toward clinical trials, revolutionizing the delivery of therapeutics to the central nervous system (CNS) for neurological disease treatment.

A MedTech company pioneering bioengineered precision intrathecal treatments

We harness cerebrospinal fluid (CSF) dynamics to design cutting‑edge medical devices that deliver intrathecal targeted therapies with unparalleled precision.

Our devices enable clearance of toxic CNS molecules, enhance the delivery of therapeutics to the CNS, and optimize CSF filtration treatments.

NEUROSTECH mission is to improve the quality of life for patients with neurodegenerative diseases and their families.

Our team comprises scientists and biotech/medtech experts with extensive experience in leading biotech companies and research innovation centers.
We are deeply focused on neurodegenerative disorders, which impact millions globally and currently lack curative treatments.

About Us

Engineering the future of neurology

Pipeline

Our proprietary technology enables the development of a robust pipeline of Medical Devices advancing towards clinical trials:

Fully implantable pumpless intrathecal devices enable two key CNS delivery modalities.
Stand-alone and extracorporeal smart catheters for CSF filtration.

INVERLEASE device

A fully implantable solution designed for pseudo-delivery of immunotherapies to treat neurodegenerative diseases.

More Info

Why choose our CSF filtration system

Extracorporeal Catheter

Optimized catheters for extracorporeal CSF filtration (liquourpheresis) and lumbar drainage in acute, life-threatening conditions.

More Info

What make us unique

Technology

NEUROSTECH is a global leader in harnessing the natural flow of CSF, enabling us to pioneer the development of groundbreaking medical devices.

Our innovations include: